We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App





Siemens Demonstrates Groundbreaking, New Innovations in Imaging, Diagnostics and Therapy at AACC 2020 Virtual Event

By LabMedica International staff writers
Posted on 14 Dec 2020
Siemens Healthineers (Erlangen, Germany) provided live demonstrations of the company’s groundbreaking, new innovations in imaging, diagnostics and therapy at the all virtual 2020 AACC Annual Scientific Meeting held on December 13-17.

Attendees of the 2020 AACC Virtual Meeting Platform discovered the power of comprehensive multidisciplinary workflow solution by viewing how Siemens’ intelligent analyzers, Atellica Diagnostics IT, Aptio Automation, and the company’s Healthcare Consulting Solutions team combined can take workflow optimization to the next level. More...
Atellica Diagnostics IT provides scalable, easy-to-use solutions to simplify tasks and maximize the effectiveness of the laboratory and its staff. Siemens demonstrated how Atellica Diagnostics IT can enhance visibility, automate processes, and centralize management across instruments, automation, sites, and networks. The company showcased its broad range of hemostasis testing solutions that offer the scalability needed for accurate testing in both low and high-volume testing environments.

Siemens also offered expert-led virtual demonstrations of its broad portfolio of trusted assays for nearly every type of disease that deliver accurate, clinically relevant results, at all access points for patient testing. Attendees were also able to engage in one-on-one conversations, have exclusive access to Siemens’ experts, and participate in live demonstrations of the company’s critical care testing products and chronic disease management at the point of care. The company also demonstrated its full range of antibody, antigen and molecular SARS-CoV-2 tests at the all virtual 2020 AACC.



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Legionella Pneumophila Test
CHORUS Legionella Urinary Antigen
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.